Trial Activity
Clinical trial IDs can clarify the science, but they can also be easy to overread. This view keeps registry facts separate from product status.
Unique Trial IDs
323
NCT-linked records
Linked Records
271
records with trial IDs
Industry-Linked
115
trial IDs tied to industry records
Status Verified
26
linked records with current status support
Trial Status Mix
A completed trial does not automatically mean an available product. These statuses are kept separate on purpose.
Completed
116
Active
105
Discontinued
57
Unknown
41
Marketed
3
Paused
2
Approved
1
323 trials · 115 industry-linked · 55 status confirmed · 24 strong evidenceShowing first 200; export includes all filtered rows.
| Trial | Linked Program | Organization | Stage / Status | Type / Modality | Evidence | Open |
|---|---|---|---|---|---|---|
NCT00912041 Industry-linked | Blackrock NeuroPort BCI System +1 linked records | Blackrock Neurotech; BrainGate Consortium | Interventional/NAMarketed ActiveMarketed | Software/Neurotech BCI/Neurotech | registry+companyregistry+institution Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01894802 Industry-linked | Blackrock NeuroPort BCI System | Blackrock Neurotech | Marketed Marketed | Software/Neurotech BCI/Neurotech | registry+company Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03834857 Industry-linked | Synchron Stentrode / SWITCH BCI | Synchron | Interventional/NA Active | Software/Neurotech BCI/Neurotech | registry+publication+company Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT06429735 Industry-linked | Neuralink N1 Implant / Telepathy | Neuralink | Interventional/NA Active | Software/Neurotech BCI/Neurotech | registry+company Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT06810219 Industry-linked | Cognixion ONE Axon-R BCI Platform | Cognixion | Interventional/NA Active | Software/Neurotech BCI/Neurotech | company Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT07224256 Industry-linked | Neuralink N1 Implant / Telepathy | Neuralink | Interventional/NA Active | Software/Neurotech BCI/Neurotech | registry+company Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT07521930 Industry-linked | Precision Neuroscience Layer 7 Cortical Interface | Precision Neuroscience | Approved Active | Software/Neurotech BCI/Neurotech | regulatory Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT07543367 Industry-linked | Synchron Stentrode / SWITCH BCI | Synchron | Interventional/NA Active | Software/Neurotech BCI/Neurotech | registry+publication+company Reviewed 2026-06-10 | ClinicalTrials.gov |
ISRCTN59733689 Industry-linked | LY3056480 by Audion Therapeutics | Audion Therapeutics BV | Phase 2 Discontinued | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | No registry link |
NCT00394056 Industry-linked | Vestipitant tinnitus study by GSK | GlaxoSmithKline | Phase 2 Completed | Therapeutic Small Molecule | company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT00405886 Industry-linked | Neramexane by Merz | Merz Pharmaceuticals GmbH | Phase 3 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT00666809 Industry-linked | Vardenafil (Levitra) by Bayer for tinnitus | Bayer AG | Phase 2 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT00739635 Industry-linked | Neramexane by Merz | Merz Pharmaceuticals GmbH | Phase 3 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT00772980 Industry-linked | Neramexane by Merz | Merz Pharmaceuticals GmbH | Phase 3 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT00827008 Industry-linked | Neramexane by Merz | Merz Pharmaceuticals GmbH | Phase 3 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT00955799 Industry-linked | Neramexane by Merz | Merz Pharmaceuticals GmbH | Phase 3 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT00957788 Industry-linked | NST-001 by NeuroSystec for tinnitus | NeuroSystec Corporation | Phase 1 Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT01084525 Industry-linked | OTO-104 (dexamethasone) by Otonomy | Otonomy | Phase 3 Discontinued | Therapeutic Steroid/Anti-inflammatory | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT01174979 Industry-linked | Transtympanic caroverine by Phafag | Phafag AG | Phase 3 Paused | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT01302873 Industry-linked | Selurampanel (BGG492) by Novartis | Novartis Pharmaceuticals | Phase 2 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT01412177 Industry-linked | OTO-104 (dexamethasone) by Otonomy | Otonomy | Phase 3 Discontinued | Therapeutic Steroid/Anti-inflammatory | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT01518920 Industry-linked | PF-04958242 by Biogen/Pfizer for age-related hearing loss | Biogen | Phase 1 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT01621256 Industry-linked | Ancrod (Viprinex/NM-V) for sudden sensorineural hearing loss | Nordmark Arzneimittel GmbH & Co. KG | Phase 1/2 Completed | Therapeutic Biologic | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02257983 Industry-linked | EPI-743 by Edison Pharmaceuticals for noise-induced hearing loss | Edison Pharmaceuticals Inc. | Phase 2 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02315508 Industry-linked | AUT00063 by Autifony Therapeutics | Autifony Therapeutics Limited | Phase 2 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02345031 Industry-linked | AUT00063 by Autifony Therapeutics | Autifony Therapeutics Limited | Phase 2 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02373228 Industry-linked | Phonak Optimization of Music Compression study | Phonak AG | Interventional/NA Completed | Software/Neurotech Hearing Aid/Software | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02612337 Industry-linked | OTO-104 (dexamethasone) by Otonomy | Otonomy | Phase 3 Discontinued | Therapeutic Steroid/Anti-inflammatory | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02648542 Industry-linked | Soterix CAS + HD-tDCS Tinnitus Pilot Study | Soterix Medical | Observational/NA Completed | Software/Neurotech BCI/Neurotech | registry+publication+company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02727442 Industry-linked | OTO-104 (dexamethasone) by Otonomy | Otonomy | Phase 3 Discontinued | Therapeutic Steroid/Anti-inflammatory | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02832128 Industry-linked | AUT00063 by Autifony Therapeutics | Autifony Therapeutics Limited | Phase 2 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02839759 Industry-linked | TELLYHealth hearing aid education and adaptation system | Healthcare Technologies and Methods, LLC | Interventional/NA Completed | Software/Neurotech Hearing Aid/Software | registry+database Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT02997189 Industry-linked | OTO-104 (dexamethasone) by Otonomy | Otonomy | Phase 3 Discontinued | Therapeutic Steroid/Anti-inflammatory | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT03331627 Industry-linked | Strekin STR001 for Sudden Sensorineural Hearing Loss | Strekin AG | Phase 3 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT03361527 Industry-linked | Advanced Bionics StereoZoom binaural beamformer study | Advanced Bionics | Observational/NA Completed | Software/Neurotech Cochlear/Auditory Implant | registry+company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT03410017 Industry-linked | Cochlear Functional Listening Index - Paediatric normative study | Cochlear | Observational/NA Completed | Diagnostic Diagnostic | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT03512951 Industry-linked | Sonova EXTEND remote-microphone sound externalization algorithm study | Sonova AG | Interventional/NA Completed | Software/Neurotech Hearing Aid/Software | registry+publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT03603314 Industry-linked | SENS-401 (Arazasetron) by Sensorion | Sensorion | Phase 2 Active | Therapeutic Small Molecule | company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT03664674 Industry-linked | OTO-104 (dexamethasone) by Otonomy | Otonomy | Phase 3 Discontinued | Therapeutic Steroid/Anti-inflammatory | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT03900897 Industry-linked | MED-EL SYNCHRONY PIN pediatric expanded-indications study | MED-EL Corporation | Interventional/NA Completed | Device Cochlear/Auditory Implant | registry+company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04018911 Industry-linked | Sonova hearing-aid noise-reduction algorithm evaluation | Sonova AG | Interventional/NA Completed | Software/Neurotech Hearing Aid/Software | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04132882 Industry-linked | TRPHARM sodium thiosulfate compassionate use program | TRPHARM | Expanded Access Active | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04231396 Industry-linked | Clearly Audiobooks by BioSpeech | BioSpeech | Interventional/NA Completed | Procedure/Rehab Behavioral/Rehabilitation | registry+company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04271761 Industry-linked | Cochlear Carina System CAMSEN post-market study | Cochlear | Observational/NA Completed | Device Cochlear/Auditory Implant | registry-results Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04279236 Industry-linked | Oticon Medical Ponto Implant System MIPS study | Oticon Medical | Observational/NA Completed | Device Cochlear/Auditory Implant | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04310202 Industry-linked | Oticon Medical Ponto BHX Implant System study | Oticon Medical | Observational/NA Completed | Device Cochlear/Auditory Implant | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04473729 Industry-linked | Listening2Faces by Smarty Ears | Smarty Ears | Interventional/NA Completed | Procedure/Rehab Behavioral/Rehabilitation | registry+company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04604548 Industry-linked | KH176 by Khondrion for m.3243A>G mitochondrial disease | Khondrion BV | Phase 2 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04777565 Industry-linked | MED-EL HEARO robotic cochlear implantation procedure study | MED-EL | Interventional/NA Completed | Procedure/Rehab Procedure/Rehab | registry+publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04777669 Industry-linked | York Sound babble noise-reduction algorithm for cochlear implant users | York Sound Inc. | Early Phase 1 Unknown | Software/Neurotech Hearing Aid/Software | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT04961099 Industry-linked | HY01 by Heyu for sudden sensorineural hearing loss | Heyu (Suzhou) Pharmaceutical Technology Co., Ltd. | Phase 1 Unknown | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05061758 Industry-linked | LY3056480 by Audion Therapeutics | Audion Therapeutics BV | Phase 2 Discontinued | Therapeutic Small Molecule | publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05106413 Industry-linked | Sonova rechargeable CROS transmitter benefit study | Sonova AG | Interventional/NA Discontinued | Software/Neurotech Hearing Aid/Software | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05258773 Industry-linked | SENS-401 (Arazasetron) by Sensorion | Sensorion | Phase 2 Active | Therapeutic Small Molecule | company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05284903 Industry-linked | Sonova/Phonak hearing-aid spatial-configurations study | Sonova AG | Interventional/NA Completed | Software/Neurotech Hearing Aid/Software | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05507372 Industry-linked | Pimozide for post-COVID tinnitus by Applied Biology | Applied Biology, Inc. | Interventional/NA Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05566353 Industry-linked | Cochlear Remote Check | Cochlear | Marketed Marketed | Software/Neurotech Hearing Aid/Software | company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05628233 Industry-linked | SENS-401 (Arazasetron) by Sensorion | Sensorion | Phase 2 Active | Therapeutic Small Molecule | company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05645432 Industry-linked | Brexanolone by Supernus for tinnitus | Supernus Pharmaceuticals, Inc. | Phase 2 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05828017 Industry-linked | Sonova hearing-aid frequency-response curve study | Sonova AG | Interventional/NA Completed | Software/Neurotech Hearing Aid/Software | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT05901480 Industry-linked | OTOV101N + OTOV101C by OtoVia Therapeutics | OtoVia Therapeutics | Interventional/NA Unknown | Therapeutic Gene Therapy | registry+publication Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT06025032 Industry-linked | HG205 RNA base-editing therapy by HuidaGene | HuidaGene Therapeutics Co., Ltd. | Early Phase 1 Discontinued | Therapeutic RNA Therapy | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT06517888 Industry-linked | AK-antiVEGF by Eli Lilly and Akouos | Eli Lilly and Company | Phase 1/2 Active | Therapeutic Gene Therapy | trial Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT06598059 Industry-linked | Cochlear CI632D dexamethasone-eluting electrode array | Cochlear | Interventional/NA Active | Device Cochlear/Auditory Implant | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT06634784 Industry-linked | MED-EL BONEBRIDGE BCI 602 pediatric premarket study | MED-EL | Observational/NA Completed | Device Cochlear/Auditory Implant | registry+company Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT06723262 Industry-linked | MED-EL FS4T Tonotopic Cochlear Implant Fitting Study | MED-EL | Interventional/NA Active | Procedure/Rehab Cochlear/Auditory Implant | trial Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT06737185 Industry-linked | MED-EL EAFS4T Tonotopic Fitting Algorithm Study | MED-EL | Interventional/NA Active | Software/Neurotech Hearing Aid/Software | trial Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT06960616 Industry-linked | Cochlear Population Mean Mapping Strategy | Cochlear | Interventional/NA Active | Software/Neurotech Cochlear/Auditory Implant | trial Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT07012746 Industry-linked | TJ0113 Capsules by Hangzhou PhecdaMed | Hangzhou PhecdaMed Co., Ltd. | Interventional/NA Active | Therapeutic Small Molecule | trial Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT07472023 Industry-linked | Truway Health HEAR-RESTORE exploratory inner-ear regenerative study | Truway Health, Inc. | Phase 1 Active | Therapeutic Regenerative Medicine | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT07580287 Industry-linked | Oticon Medical non-surgical bone conduction device comparison study | Oticon Medical | Interventional/NA Active | Device Cochlear/Auditory Implant | registry Reviewed 2026-06-09 | ClinicalTrials.gov |
NCT06249919 Industry-linked | NS101 by Neuracle Science | Neuracle Science Co., Ltd. | Phase 1/2 Active | Therapeutic Biologic | trial Reviewed 2026-06-08 | ClinicalTrials.gov |
NCT06765993 Industry-linked | Isosorbide Oral Solution by Lunan Better Pharmaceutical | Lunan Better Pharmaceutical Co., Ltd. | Phase 2/3 Active | Therapeutic Small Molecule | trial Reviewed 2026-06-08 | ClinicalTrials.gov |
NCT07288580 Industry-linked | EHT102 by EuHearing | Shanghai EuHearing Therapeutics Co., Ltd | Phase 1/2 Active | Therapeutic Gene Therapy | trial Reviewed 2026-06-08 | ClinicalTrials.gov |
NCT07472907 Industry-linked | CIL001 (Paliroden) by Cilcare | Cilcare SAS | Phase 1/2 Active | Therapeutic Small Molecule | trial Reviewed 2026-06-08 | ClinicalTrials.gov |
NCT00802425 Industry-linked | AM-111 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Biologic | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT00860808 Industry-linked | AM-101 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT01270282 Industry-linked | AM-101 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT01444846 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT01451853 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT01452607 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT01803646 Industry-linked | AM-101 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT01934010 Industry-linked | AM-101 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02040194 Industry-linked | AM-101 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02040207 Industry-linked | AM-101 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02132130 Industry-linked | CGF166 by Novartis | Novartis | Phase 1/2 Completed | Therapeutic Gene Therapy | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02259595 Industry-linked | NHPN-1010 | Otologic Pharmaceutics | Phase 1 Completed | Therapeutic Small Molecule | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02561091 Industry-linked | AM-111 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Biologic | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02603081 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02779192 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02809118 Industry-linked | AM-111 by Auris Medical and Altamira | Altamira Therapeutics | Phase 3 Discontinued | Therapeutic Biologic | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT02819856 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT03300687 Industry-linked | FX-322 by Frequency Therapeutics | Frequency Therapeutics | Phase 2 Discontinued | Therapeutic Regenerative Medicine | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT03325790 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT03616223 Industry-linked | FX-322 by Frequency Therapeutics | Frequency Therapeutics | Phase 2 Discontinued | Therapeutic Regenerative Medicine | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT03918109 Industry-linked | OTO-313 by Otonomy | Otonomy | Phase 2 Discontinued | Therapeutic Small Molecule | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT04120116 Industry-linked | FX-322 by Frequency Therapeutics | Frequency Therapeutics | Phase 2 Discontinued | Therapeutic Regenerative Medicine | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT04129775 Industry-linked | OTO-413 by Otonomy | Otonomy | Phase 2 Discontinued | Therapeutic Biologic | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT04262336 Industry-linked | DB-020 by Regeneron and Decibel | Regeneron Pharmaceuticals | Phase 1 Completed | Therapeutic Drug Delivery | publication Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT04462198 Industry-linked | PIPE-505 by Pipeline Therapeutics | Contineum Therapeutics | Phase 1/2 Completed | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT04601909 Industry-linked | FX-322 by Frequency Therapeutics | Frequency Therapeutics | Phase 2 Discontinued | Therapeutic Regenerative Medicine | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT04629664 Industry-linked | FX-322 by Frequency Therapeutics | Frequency Therapeutics | Phase 2 Discontinued | Therapeutic Regenerative Medicine | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT04677972 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT04829214 Industry-linked | OTO-313 by Otonomy | Otonomy | Phase 2 Discontinued | Therapeutic Small Molecule | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT05086276 Industry-linked | FX-322 by Frequency Therapeutics | Frequency Therapeutics | Phase 2 Discontinued | Therapeutic Regenerative Medicine | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT05664100 Industry-linked | FX-345 by Frequency Therapeutics | Frequency Therapeutics | Phase 1 Discontinued | Therapeutic Regenerative Medicine | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT05776459 Industry-linked | AC102 by AudioCure Pharma | AudioCure Pharma | Phase 2 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT05788536 Industry-linked | Otarmeni by Regeneron | Regeneron Pharmaceuticals | Approved Approved | Therapeutic Gene Therapy | regulatory Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT05821959 Industry-linked | AK-OTOF by Eli Lilly and Akouos | Eli Lilly and Company | Phase 2 Active | Therapeutic Gene Therapy | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT06340633 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT06370351 Industry-linked | SENS-501 by Sensorion | Sensorion | Phase 1/2 Active | Therapeutic Gene Therapy | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT06521190 Industry-linked | ACOU085 by Acousia Therapeutics | Acousia Therapeutics GmbH | Phase 2 Active | Therapeutic Small Molecule | company Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT06699797 Industry-linked | Envoy Medical Acclaim Cochlear Implant | Envoy Medical | Phase 2/3 Active | Device Cochlear/Auditory Implant | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT06859788 Industry-linked | SPI-1005 by Sound Pharmaceuticals | Sound Pharmaceuticals | Phase 3 Active | Therapeutic Small Molecule | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT07032038 Industry-linked | Rincell-1 by Rinri Therapeutics | Rinri Therapeutics | Phase 1/2 Active | Therapeutic Cell Therapy | trial Reviewed 2026-05-31 | ClinicalTrials.gov |
NCT00000361 Sponsor/institution-led | NIDCD Methotrexate and Corticosteroid Autoimmune Inner Ear Disease Study | Government-led study | Phase 3 Discontinued | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00264407 Sponsor/institution-led | Hormone replacement therapy auditory-aging exposure study | Institution-led study | Not applicable Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00317850 Sponsor/institution-led | Gabapentin tinnitus trial | Institution-led study | Phase 2/3 Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00416143 Sponsor/institution-led | Prednisone SSNHL steroid study cluster | Institution-led study | Phase 3 Active | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00552786 Sponsor/institution-led | National Taiwan University NAC Noise-Induced Hearing Loss Study | Institution-led study | Phase 2 Completed | Therapeutic Small Molecule | registry+publication Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00578760 Sponsor/institution-led | Aspirin cisplatin-ototoxicity prevention study | Institution-led study | Not applicable Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00584155 Sponsor/institution-led | Lactated Ringer's With Ofloxacin Cisplatin Otoprotection Study | Institution-led study | Phase 1 Discontinued | Therapeutic Drug Delivery | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00591019 Sponsor/institution-led | Modafinil Tinnitus Attention Study | Institution-led study | Phase 1 Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00591994 Sponsor/institution-led | Piribedil tinnitus crossover study | Institution-led study | Not applicable Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00596531 Sponsor/institution-led | OHSU Acamprosate Tinnitus Study | Institution-led study | Phase 1 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00765635 Sponsor/institution-led | Hospital Clinic Barcelona Cerumenolytic Ear Drops Study | Institution-led study | Phase 4 Completed | Therapeutic Small Molecule | publication Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00789061 Sponsor/institution-led | National Taiwan University Proton Pump Inhibitor SLC26A4 Hearing-Loss Study | Institution-led study | Phase 2/3 Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00841230 Sponsor/institution-led | Deanxit tinnitus add-on study | Institution-led study | Phase 4 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT00890526 Sponsor/institution-led | Tinnitus Retraining Therapy Sound Therapy Study for Hyperacusis | Institution-led study | Phase 1 Completed | Procedure/Rehab Behavioral/Rehabilitation | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01108601 Sponsor/institution-led | McGill Transtympanic Ringer's Lactate Cisplatin Otoprotection Study | Institution-led study | Phase 1/2 Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01150305 Sponsor/institution-led | Dominant deafness genetic epidemiology blood-sample study | Institution-led study | Not applicable Completed | Diagnostic Genetic/Biomarker Study | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01186185 Sponsor/institution-led | Fludrocortisone Sudden Sensorineural Hearing Loss Study | Institution-led study | Phase 1 Discontinued | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01223638 Sponsor/institution-led | Congenital Hypothyroidism Hearing-Loss Audiometry Study | Institution-led study | Observational/NA Discontinued | Diagnostic Diagnostic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01264510 Sponsor/institution-led | Bone-Anchored Hearing Aid Effectiveness Study | Institution-led study | Phase 4 Discontinued | Device Bone Conduction Implant | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01267994 Sponsor/institution-led | Anakinra Studies in Autoimmune Inner Ear Disease and Steroid-Resistant SSNHL | Investigator-led study | Phase 1/2 Completed | Therapeutic Biologic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01302327 Sponsor/institution-led | Exenatide Wolfram Syndrome Study | Institution-led study | Interventional/NA Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01372904 Sponsor/institution-led | Meir intratympanic dexamethasone cisplatin-otoprotection study | Institution-led study | Phase 4 Completed | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01526408 Sponsor/institution-led | House Research Institute Famciclovir Study in Unilateral Meniere's Disease | Institution-led study | Phase 3 Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01574313 Sponsor/institution-led | Chi Mei Stellate Ganglion Block Meniere's Disease Study | Institution-led study | Phase 4 Completed | Procedure/Rehab Procedure/Rehab | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01588925 Sponsor/institution-led | São Paulo dexamethasone/hyaluronic acid cochlear-implant study | Institution-led study | Phase 2 Completed | Therapeutic Drug Delivery | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01663467 Sponsor/institution-led | Internet and Smartphone Tinnitus Retraining Therapy Study | Institution-led study | Interventional/NA Discontinued | Software/Neurotech Digital Therapeutic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01693809 Sponsor/institution-led | Caffeine VEMP Screening Study | Institution-led study | Phase 4 Unknown | Diagnostic Diagnostic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01727492 Sponsor/institution-led | Antioxidant prevention study for noise-induced hearing loss and tinnitus | Institution-led study | Not applicable Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01732289 Sponsor/institution-led | National Taiwan Genetic Screening Study of Age-Related Hearing Loss | Institution-led study | Early Phase 1 Completed | Diagnostic Diagnostic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01773278 Sponsor/institution-led | Colorado SLOS Cholesterol and Antioxidant Study | Institution-led study | Phase 2 Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01802190 Sponsor/institution-led | POU4F3 and SLC17A8 Deafness Genetic Testing Study | Institution-led study | Observational/NA Discontinued | Diagnostic Diagnostic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01886729 Sponsor/institution-led | tDCS timing study for acute tinnitus | Institution-led study | Not applicable Unknown | Procedure/Rehab Non-invasive Neuromodulation | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01967498 Sponsor/institution-led | Montelukast Hearing and Vestibular Study Cluster | Institution-led study cluster | Phase 4 Active | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT01969474 Sponsor/institution-led | Cannabis Tinnitus Study | Institution-led study | Phase 1 Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02026479 Sponsor/institution-led | Peking postauricular dexamethasone sudden-hearing-loss study | Institution-led study | Interventional/NA Unknown | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02038972 Sponsor/institution-led | Autologous Cord Blood Stem Cell Infusion Study for Pediatric Acquired Hearing Loss | Investigator-led study | Phase 1/2 Completed | Therapeutic Cell Therapy | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02049073 Sponsor/institution-led | Zonisamide and Methylprednisolone Noise-Induced Hearing Loss Prevention Study | Institution-led study | Phase 1/2 Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02062333 Sponsor/institution-led | Erciyes Hypotensive Anesthesia Cochlea Study | Institution-led study | Phase 4 Completed | Procedure/Rehab Procedure/Rehab | publication Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02088866 Sponsor/institution-led | UC Davis Transdermal Lidocaine Tinnitus Study | Institution-led study | Early Phase 1 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02095262 Sponsor/institution-led | Nottingham Auditory Games for Tinnitus Training Study | Institution-led study | Phase 1 Completed | Software/Neurotech Behavioral/Rehabilitation | registry+publication Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02266160 Sponsor/institution-led | HaEmek EMLA 5% Cream Tinnitus Study | Institution-led study | Phase 4 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02290015 Sponsor/institution-led | Acupuncture tinnitus clinical-study cluster | Institution-led study cluster | Not applicable Active | Procedure/Rehab Complementary/Acupuncture Procedure | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02382068 Sponsor/institution-led | Moberly intratympanic dexamethasone cisplatin-otoprotection study | Investigator-led study | Interventional/NA Discontinued | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02414152 Sponsor/institution-led | Anakinra Studies in Autoimmune Inner Ear Disease and Steroid-Resistant SSNHL | Investigator-led study | Phase 1/2 Completed | Therapeutic Biologic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02425397 Sponsor/institution-led | AP-HP OTOPLAT platinum ototoxicity pharmacogenetics study | Institution-led study | Not applicable Completed | Diagnostic Genetic/Biomarker Study | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02508220 Sponsor/institution-led | Syntocinon oxytocin nasal-spray tinnitus study | Investigator-led study | Not applicable Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02616172 Sponsor/institution-led | Autologous Bone Marrow Infusion Study for Sensorineural Hearing Loss | Investigator-led study | Phase 1/2 Paused | Therapeutic Cell Therapy | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02653547 Sponsor/institution-led | Regensburg rTMS tinnitus duration and frequency study | Institution-led study | Not applicable Completed | Procedure/Rehab Neuromodulation | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02662192 Sponsor/institution-led | Auditory rehabilitation comparator arm | Institution-led study | Not applicable Completed | Procedure/Rehab Behavioral/Rehabilitation | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02737670 Sponsor/institution-led | St Joseph University sulodexide tinnitus study | Institution-led study | Phase 2 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02826694 Sponsor/institution-led | UNC NC NEXUS newborn exome sequencing study | Institution-led study | Not applicable Completed | Diagnostic Genetic/Diagnostic Sequencing | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02829268 Sponsor/institution-led | Washington University Dantrolene Study in Wolfram Syndrome | Institution-led study | Phase 1/2 Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02882477 Sponsor/institution-led | Hadassah Wolfram Syndrome Type 2 Combination Therapy Study | Institution-led study | Phase 2 Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02903355 Sponsor/institution-led | Southern Illinois D-Methionine Noise-Induced Hearing Loss Study | Institution-led study | Phase 3 Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02925208 Sponsor/institution-led | Cochlear implant surgery radiology classification study | Institution-led study | Not applicable Completed | Procedure/Rehab Surgical/Procedural Study | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT02951715 Sponsor/institution-led | Zinc gluconate tinnitus and noise-induced hearing-loss study | Institution-led study | Not applicable Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03248856 Sponsor/institution-led | Triamcinolone Levels in Cochlear Perilymph Study | Investigator-led study | Phase 1 Completed | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03255473 Sponsor/institution-led | Colorado dexamethasone versus prednisone SSNHL study | Institution-led study | Phase 2 Discontinued | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03265197 Sponsor/institution-led | Intratympanic Lidocaine plus Dexamethasone Tinnitus Study | Investigator-led study | Phase 1 Completed | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03321006 Sponsor/institution-led | Antidepressant plus hearing-aid mood and cognition study | Institution-led study | Phase 4 Completed | Procedure/Rehab Hearing Aid/Medication Combination Study | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03365011 Sponsor/institution-led | Nitrous oxide tinnitus crossover trial | Institution-led study | Phase 4 Completed | Therapeutic Small Molecule/Inhaled Gas | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03374514 Sponsor/institution-led | Hospital Italiano topical dexamethasone cochlear-implant study | Institution-led study | Phase 3 Unknown | Device Cochlear/Auditory Implant | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03425045 Sponsor/institution-led | Ginkgo biloba tinnitus study cluster | Institution-led study cluster | Not applicable Completed | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03557879 Sponsor/institution-led | Hearing-impairment exome sequencing study | Institution-led study | Not applicable Unknown | Diagnostic Genetic/Diagnostic Sequencing | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03595163 Sponsor/institution-led | Shanghai propofol versus sevoflurane cochlear implant anesthesia study | Institution-led study | Not applicable Unknown | Procedure/Rehab Procedural Anesthesia Study | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03638323 Sponsor/institution-led | Presbycusis and lexical-disorder speech-therapy assessment study | Institution-led study | Not applicable Completed | Procedure/Rehab Behavioral/Rehabilitation | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03674853 Sponsor/institution-led | Xijing Wuling Capsule chronic tinnitus study | Institution-led study | Not applicable Completed | Therapeutic Small Molecule/Traditional Medicine | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03685461 Sponsor/institution-led | Electrocochleography hearing-study cluster | Institution-led study cluster | Not applicable Completed | Diagnostic Electrophysiology/Diagnostic Assessment | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03694340 Sponsor/institution-led | Pediatric cochlear implant MAP reprogramming study | Institution-led study | Not applicable Completed | Software/Neurotech Cochlear Implant Programming Software/Workflow | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03700268 Sponsor/institution-led | AI-assisted cochlear implant programming study | Institution-led study | Not applicable Unknown | Software/Neurotech Cochlear Implant Programming Software/Workflow | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03837665 Sponsor/institution-led | Academic Platelet-Rich Plasma Otologic Studies | Institution-led study | Phase 2/3 Unknown | Therapeutic Biologic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03867396 Sponsor/institution-led | Cochlear implant alone comparator arm | Institution-led study | Not applicable Completed | Device Cochlear/Auditory Implant | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03886168 Sponsor/institution-led | Pediatric image-guided cochlear implant programming study | Institution-led study | Not applicable Completed | Software/Neurotech Cochlear Implant Programming Software/Workflow | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT03974867 Sponsor/institution-led | Oral versus intratympanic glucocorticoid ISSNHL vestibular prognosis study | Institution-led study | Not applicable Unknown | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04070937 Sponsor/institution-led | Jessa DFNA9 Vestibulopathy Imaging and Genetics Study | Institution-led study | Observational/NA Active | Diagnostic Diagnostic | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04127708 Sponsor/institution-led | Acupuncture tinnitus clinical-study cluster | Institution-led study cluster | Not applicable Active | Procedure/Rehab Complementary/Acupuncture Procedure | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04129697 Sponsor/institution-led | Intratympanic dexamethasone versus methylprednisolone sudden-hearing-loss study | Institution-led study | Not applicable Unknown | Therapeutic Steroid/Anti-inflammatory | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04129983 Sponsor/institution-led | Prednisone plus stimulation sudden-deafness study | Investigator-led study | Not applicable Unknown | Procedure/Rehab Combination Drug/Procedure Study | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04152551 Sponsor/institution-led | Hospital for Special Surgery Risedronate Study in OI-Related Hearing Loss | Institution-led study | Phase 4 Active | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04192656 Sponsor/institution-led | Beijing PAP plus Medication Study in ISSHL with Obstructive Sleep Apnea | Institution-led study | Phase 4 Active | Procedure/Rehab Procedure/Rehab | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04200664 Sponsor/institution-led | Audiovestibular biomarker DNA biobanking study | Institution-led study | Not applicable Completed | Diagnostic Genetic/Biomarker Study | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04207866 Sponsor/institution-led | Teleconference auditory training services study | Institution-led study | Not applicable Unknown | Procedure/Rehab Behavioral/Rehabilitation | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04210310 Sponsor/institution-led | NYU High-Dose Intranasal Oxytocin Tinnitus Study | Institution-led study | Phase 3 Discontinued | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04226456 Sponsor/institution-led | Intratympanic N-Acetylcysteine Cisplatin Otoprotection Studies | Institution-led study | Phase 4 Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |
NCT04291209 Sponsor/institution-led | Intratympanic N-Acetylcysteine Cisplatin Otoprotection Studies | Institution-led study | Phase 4 Unknown | Therapeutic Small Molecule | registry Reviewed 2026-06-10 | ClinicalTrials.gov |